Boon Cher Goh

Research interests

Publications

• Resveratrol for cancer therapy: Challenges and future perspectives

  Cancer Letters · 2021 · https://doi.org/10.1016/j.canlet.2021.05.001

• First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors

  Cancer Discovery · 2020 · https://doi.org/10.1158/2159-8290.cd-20-0868

• Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

  Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2017.77.0388

• Dual role of autophagy in hallmarks of cancer

  Oncogene · 2017 · https://doi.org/10.1038/s41388-017-0046-6

• Exosome-Mediated Metastasis: From Epithelial–Mesenchymal Transition to Escape from Immunosurveillance

  Trends in Pharmacological Sciences · 2016 · https://doi.org/10.1016/j.tips.2016.04.006

• Targeting transcription factor STAT3 for cancer prevention and therapy

  Pharmacology & Therapeutics · 2016 · https://doi.org/10.1016/j.pharmthera.2015.10.004

• Clinical activity and safety of cobimetinib (cobi) and atezolizumab in colorectal cancer (CRC).

  Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2016.34.15_suppl.3502

• The genomic landscape of nasopharyngeal carcinoma

  Nature Genetics · 2014 · https://doi.org/10.1038/ng.3006

• Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

  EMBO Molecular Medicine · 2013 · https://doi.org/10.1002/emmm.201201823

• Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.41.2395

• Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study

  The Lancet Oncology · 2010 · https://doi.org/10.1016/s1470-2045(10)70203-5

• Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

  Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.02.147

• Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs

  Clinical Pharmacokinetics · 2005 · https://doi.org/10.2165/00003088-200544030-00005

Current projects

No projects listed.